/PRNewswire/ After twenty years as one of the first personalized oncology companies, Indivumed today announced its evolution into Indivumed Therapeutics.
Crown Bioscience, a global contract research organization (CRO) and JSR Life Sciences company, announced today that it has completed its acquisition of the IndivuServ business unit of Indivumed GmbH
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, has announced it has entered into an agreement to acquire the IndivuServ business unit of Indivumed GmbH.
Acquisition expands global service offering to include access and analysis of unique clinical biospecimens Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences
/PRNewswire/ Indivumed GmbH ("Indivumed") and CELLphenomics GmbH ("CELLphenomics") today announced a partnership to create a unique platform for faster and.